We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

176 hedge funds and large institutions have $845M invested in DermTech, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 76 increasing their positions, 30 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 30

18% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 40

4% more funds holding

Funds holding: 169176 (+7)

7% less call options, than puts

Call options by funds: $16.9M | Put options by funds: $18.1M

17% less capital invested

Capital invested by funds: $1.01B → $845M (-$169M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
176
Holders Change
+7
Holders Change %
+4.14%
% of All Funds
3.06%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
47
Increased
76
Reduced
30
Closed
40
Calls
$16.9M
Puts
$18.1M
Net Calls
-$1.25M
Net Calls Change
-$8.05M
Name Holding Trade Value Shares
Change
Change in
Stake
TA
26
Tamarack Advisers
California
$5.61M +$2.09M +51,000 +61%
Citigroup
27
Citigroup
New York
$4.76M +$1.49M +36,334 +46%
CS
28
Credit Suisse
Switzerland
$4.62M +$746K +18,172 +20%
Citadel Advisors
29
Citadel Advisors
Florida
$4.21M +$877K +21,360 +27%
N
30
Nuveen
North Carolina
$3.96M +$1.93M +47,046 +98%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.71M +$1.6M +39,001 +78%
GIA
32
Gladstone Institutional Advisory
Florida
$3.5M +$97.4K +2,371 +3%
PGM
33
Parian Global Management
New York
$3.35M +$3.31M +80,700 New
ETCM
34
Evolutionary Tree Capital Management
Virginia
$3.27M +$1.03M +24,978 +47%
Jane Street
35
Jane Street
New York
$3.1M -$1.26M -30,676 -29%
AIA
36
Avalon Investment & Advisory
Texas
$3.02M +$2.99M +72,726 New
Fuller & Thaler Asset Management
37
Fuller & Thaler Asset Management
California
$2.75M -$67K -1,630 -2%
GGHC
38
Gilder Gagnon Howe & Co
New York
$2.74M +$409K +9,965 +18%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$2.67M +$86.3K +2,102 +3%
Renaissance Technologies
40
Renaissance Technologies
New York
$2.63M -$4.12M -100,300 -61%
EMFAT
41
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.49M
SOMRS
42
State of Michigan Retirement System
Michigan
$2.49M +$1.73M +42,000 +233%
Millennium Management
43
Millennium Management
New York
$2.49M +$2.46M +59,812 New
Charles Schwab
44
Charles Schwab
California
$2.46M +$1.17M +28,443 +93%
BAM
45
Belpointe Asset Management
Nevada
$2.36M -$31.2K -760 -1%
CF
46
Centaurus Financial
California
$2.12M +$647K +15,740 +45%
WMC
47
Westwood Management Corporation
Illinois
$2.12M
William Blair & Company
48
William Blair & Company
Illinois
$1.86M +$20.5K +500 +1%
Wells Fargo
49
Wells Fargo
California
$1.76M +$331K +8,052 +23%
AIC
50
AWM Investment Company
New York
$1.66M +$411K +10,000 +33%

DMTK Hedge Fund Activity: Q2 2021 in Review

176 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2021, worth a combined $845M — down 17% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DMTK positions and 40 closed out — a net gain of 7 holders — while 76 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $27.8M. The largest seller was ISZO Capital Management, cutting an estimated $30.1M.

  • 176 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2021, up from 169 in Q1 2021.
  • Funds reported $845M of DermTech, Inc. Common Stock stock for Q2 2021, down 17% quarter-over-quarter.
  • 47 funds opened new DermTech, Inc. Common Stock positions in Q2 2021 and 40 closed out, a net change of +7 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $27.8M added.
  • The largest DermTech, Inc. Common Stock seller in Q2 2021 was ISZO Capital Management, an estimated $30.1M sold.

Based on aggregated 13F filings for Q2 2021.